Access to health care
2023-03-18 12:43:22
Committed to innovation-driven development, we continue to better ourscientific and research platform, dedicate to greater self-reliance andstrength in science and technology and enhance protection of intellectualproperty rights. We also endeavor to improve the quality of our products tosupport disease prevention and control. Furthermore, we continue to deepen thecooperation between the TCM sector and others, follow the changing trend ofconsumption and champion a healthy life philosophy to safeguard people’swell-being.
n Our performance
l In 2022, a total of about RMB 1,065 million wasinvested in R&D innovation
l In 2022, 16 New scientific research projects
l In 2022, 193 ongoing research projects
l In 2022, 10 Production approvals and additional approvals obtained, including 3 approvals for newproducts and7 new product regulations on consistency evaluation ratified.
l In 2022, 88 Patent application filed , including 73 inventionpatent applications and 15 utility model patent applications.
l In 2022, 94 patents authorized including 75 inventionpatents and 19 utility model patents.
l In 2022, we obtained1 new national accreditation and 1 provincial scientific researchplatform was newly established. We have established 8 nationalscientific research platforms, 41 provincial ones and 35 municipalones.
l Both of the researcheson new indications of Naoxinqing tablets and the anti-tumor drug resistance ofGanoderma Lucidum extract were granted international invention patents underPCT(Patent Cooperation Treaty).
l Ganoderma Lucidum Spore Oil Soft-capsule’s “Inheritance and Innovation ofGanoderma, a Traditional Chinese Medicine” project won the Gold Medal ofInternational Exhibition of Inventions of Geneva.
l BYS10, a self-developed anti-cancer Category I innovative drug, wasapproved to conduct clinical trial by US FDA.
n Our Approach to Access to Health Care
We constantly increase investment in innovations, reinforce technologicalbreakthrough and continue to improve the quality and efficiency of scientificresearches and innovation benefits, striving to promote the high-quality TCMdevelopment and its global recognition and better safeguard people’s health.
We set store by the idea of “quality first” and adhere to China’sfundamental principle of “dealing with food safety issues with the mostrigorous standards, the most stringent supervision, the most severe penalties,and the most serious accountability”. Following a science-based managementmode, we continue to strengthen our “full life cycle” quality management, thequality control and medicine warning systems and further expand the coverage ofour quality activities, thereby fostering a good reputation among consumerswith high-quality products and services.
We are committed to developing primary-level healthcare, a fair pricingprinciple and innovating new marketing models. Our goals are to communicate to thepublic the idea of a healthy life, improve life quality and contribute tobetter well-being.
n Our Stories
